134 related articles for article (PubMed ID: 7783258)
1. [Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma].
Guo HB; Stoffel-Wagner B; Brennemann W; Springer W; Klingmüller D
J Tongji Med Univ; 1995; 15(1):19-25. PubMed ID: 7783258
[No Abstract] [Full Text] [Related]
2. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
Wibe E; Hannisdal E; Paus E; Aamdal S
Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
[TBL] [Abstract][Full Text] [Related]
3. Neuron-specific enolase as a tumor marker in metastatic melanoma.
Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
Am J Clin Oncol; 1994 Oct; 17(5):430-1. PubMed ID: 8092117
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
[TBL] [Abstract][Full Text] [Related]
5. Neuron-specific enolase--a serum marker for malignant melanoma.
Lorenz J; Dippold W
J Natl Cancer Inst; 1989 Nov; 81(22):1754-5. PubMed ID: 2810389
[No Abstract] [Full Text] [Related]
6. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
Wibe E; Paus E; Aamdal S
Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
[TBL] [Abstract][Full Text] [Related]
7. Serum neuron-specific enolase in metastatic Merkel cell tumors.
Giannone L; Johnson DH; Grosh WW; Davis BW; Marangos PJ; Greco FA
Med Pediatr Oncol; 1985; 13(6):357-62. PubMed ID: 3900664
[TBL] [Abstract][Full Text] [Related]
8. [Neuron-specific enolase (NSE)--a suitable tumor marker in malignant melanoma?].
Hornef S; Lux J; Rassner G
Hautarzt; 1992 Feb; 43(2):77-80. PubMed ID: 1347764
[TBL] [Abstract][Full Text] [Related]
9. Neuron-specific enolase as serum marker for malignant melanoma.
Couvreur R; Joos G; Geerts ML; Lambert J; Naeyaert JM
Lancet; 1993 Oct; 342(8877):985. PubMed ID: 8105228
[No Abstract] [Full Text] [Related]
10. Serum marker for Merkel cell tumour.
Plowman PN
Clin Radiol; 1989 Sep; 40(5):542. PubMed ID: 2619805
[No Abstract] [Full Text] [Related]
11. Neuron-specific enolase--a serum tumour marker in seminoma?
Fosså SD; Klepp O; Paus E
Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
[TBL] [Abstract][Full Text] [Related]
12. S-100 and NSE as serum markers in melanoma.
Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
[TBL] [Abstract][Full Text] [Related]
13. Serum neuron-specific enolase (NSE) as a tumour marker for the Ewing's sarcoma family of tumours.
Fizazi K; Le Cesne A; Dohollou N; Affaied S; Spielmann M; Le Chevalier T
Eur J Cancer; 1996 Sep; 32A(10):1823-4. PubMed ID: 8983301
[No Abstract] [Full Text] [Related]
14. A new standard of care for metastatic melanoma?
Sharma SP
Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638559
[No Abstract] [Full Text] [Related]
15. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Jun; 31A(6):924-8. PubMed ID: 7646923
[TBL] [Abstract][Full Text] [Related]
17. [Neuron-specific enolase and beta 2-microglobulin in the serum of patients with melanoma].
Uerlich M; Biltz H; Kreysel HW
Immun Infekt; 1988 Apr; 16(2):65-7. PubMed ID: 3292403
[TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinase-2 as a prognostic marker in advanced cutaneous melanoma.
Vuoristo MS; Kellokumpu-Lehtinen P; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E; Laine S
Acta Oncol; 2000; 39(7):877-9. PubMed ID: 11145448
[TBL] [Abstract][Full Text] [Related]
19. Serum neuron-specific enolase as a marker of small-cell carcinoma of the esophagus.
Sasajima K; Watanabe M; Ando T; Hao K; Miyashita M; Yamashita K; Onda M; Takubo K
J Clin Gastroenterol; 1990 Aug; 12(4):384-8. PubMed ID: 2168912
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.
Kamiya N; Akakura K; Suzuki H; Isshiki S; Komiya A; Ueda T; Ito H
Eur Urol; 2003 Sep; 44(3):309-14; discussion 314. PubMed ID: 12932928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
